Advancing Rheumatic Heart Disease Management in Indonesia: Strengthening Early Detection, Targeted Screening, and Prevention Strategies

Advancing Rheumatic Heart Disease Management in Indonesia: Strengthening Early Detection, Targeted Screening, and Prevention Strategies

Authors

  • Jochebet Irene Faculty of Medicine, Tarumanagara University, Special Region of Jakarta, Indonesia
  • Ciho Olfriani Faculty of Medicine, Tarumanagara University, Special Region of Jakarta, Indonesia

Keywords:

ARF, Indonesia, RHD, secondary prevention

Abstract

Background: Indonesia ranks fourth globally in rheumatic heart disease (RHD) prevalence, with a mortality rate of 4.8 per 100,000—higher than malaria. Despite global progress in RHD management, Indonesia lacks a comprehensive national prevention program. Secondary prevention strategies could significantly improve outcomes in high-risk populations by targeting disease progression. Method: This systematic review and meta-analysis examined the impact of secondary prevention on echocardiographic outcomes in Indonesian RHD patients. The review included randomized controlled trials, observational studies, quasi-experimental designs, and case-control studies, emphasizing the role of secondary prevention in mitigating disease progression. Results: Six studies meeting inclusion criteria underwent full-text analysis, with four eligible for meta-analysis. These studies revealed that secondary prevention improved echocardiographic markers, demonstrating its potential to alter disease trajectories in resource-limited settings. Conclusion: Indonesia faces challenges in RHD management due to geographical and healthcare constraints. Echocardiographic screening, a sensitive and specific diagnostic tool, is vital for early detection and monitoring. With technological advancements, cost-effective screening is increasingly feasible, even in remote areas. Strengthening early detection, targeted screening, and secondary prevention strategies is critical for reducing the RHD burden in Indonesia.

References

World Health Assembly, 71. (‎2018)‎. Rheumatic fever and rheumatic heart disease: report by the Director-General. World Health Organization. https://iris.who.int/handle/10665/276479

Watkins, D. A., Johnson, C. O., Colquhoun, S. M., Karthikeyan, G., Beaton, A., Bukhman, G., Forouzanfar, M. H., Longenecker, C. T., Mayosi, B. M., Mensah, G. A., Nascimento, B. R., Ribeiro, A. L. P., Sable, C. A., Steer, A. C., Naghavi, M., Mokdad, A. H., Murray, C. J. L., Vos, T., Carapetis, J. R., & Roth, G. A. (2017). Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. The New England journal of medicine, 377(8), 713–722. https://doi.org/10.1056/NEJMoa1603693

GBD 2019 Indonesia Subnational Collaborators (2022). The state of health in Indonesia's provinces, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. Global health, 10(11), e1632–e1645. https://doi.org/10.1016/S2214-109X(22)00371-0

Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics, Saxena, A., Kumar, R. K., Gera, R. P., Radhakrishnan, S., Mishra, S., & Ahmed, Z. (2008). Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian pediatrics, 45(7), 565–573.

Rémond, M. G., Wheaton, G. R., Walsh, W. F., Prior, D. L., & Maguire, G. P. (2012). Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011. Heart, lung & circulation, 21(10), 632–638. https://doi.org/10.1016/j.hlc.2012.05.006

Heart Foundation of New Zealand. (2014). New Zealand Guidelines for Rheumatic Fever: Diagnosis, Management and Secondary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease: 2014 Update. https://www.heartfoundation.org.nz

Zühlke, L. J., Engel, M. E., Watkins, D., & Mayosi, B. M. (2015). Incidence, prevalence and outcome of rheumatic heart disease in South Africa: a systematic review of contemporary studies. International journal of cardiology, 199, 375–383. https://doi.org/10.1016/j.ijcard.2015.06.145

Sastroasmoro, S., Madiyono, B., Oesman, I. N., Putra, S. T., & Advani, N. (1995). Survival patterns of children with rheumatic heart disease. Medical Journal of Indonesia, 4(4), 254–63. https://doi.org/10.13181/mji.v4i4.925

Colquhoun, S. M., Condon, J. R., Steer, A. C., Li, S. Q., Guthridge, S., & Carapetis, J. R. (2015). Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians. Journal of the American Heart Association, 4(7), e001282. https://doi.org/10.1161/JAHA.114.001282

Mahendradhata, Y., Trisnantoro, L., Listyadewi, S., Soewondo, P., Marthias, T. et al. (‎2017)‎. The Republic of Indonesia health system review. Health Systems in Transition, 7 (‎1)‎, WHO Regional Office for South-East Asia. https://iris.who.int/handle/10665/254716

Rodriguez-Fernandez, R., Amiya, R., Wyber, R., Widdodow, W., & Carapetis, J. (2015). Rheumatic heart disease among adults in a mining community of Papua, Indonesia: findings from an occupational cohort. Heart Asia, 7(2), 44–48. https://doi.org/10.1136/heartasia-2015-010641

Lilyasari, O., Prakoso, R., Kurniawati, Y., Roebiono, P. S., Rahajoe, A. U., Sakidjan, I., & Harimurti, G. M. (2020). Clinical Profile and Management of Rheumatic Heart Disease in Children and Young Adults at a Tertiary Cardiac Center in Indonesia. Frontiers in surgery, 7, 47. https://doi.org/10.3389/fsurg.2020.00047

Soesanto, A. M., & Suastika, L. O. S. (2020). Echocardiography Screening for Latent Rheumatic Heart Disease: What Can We Do in Indonesia?. Frontiers in surgery, 7, 46. https://doi.org/10.3389/fsurg.2020.00046

Arafuri, N., Murni, I. K., Julia, M., Nugroho, S., & Soehadi, N. (2022). Survival of Rheumatic Heart Disease in Indonesian Children. Global heart, 17(1), 71. https://doi.org/10.5334/gh.1160

Rudiktyo, E., Wind, A., Doevendans, P., Siswanto, B. B., Cramer, M.-J., & Soesanto, A. M. (2022). Characteristics of patients with rheumatic heart disease in a national referral hospital in Indonesia. Medical Journal of Indonesia, 31(3), 178–85. https://doi.org/10.13181/mji.oa.226150

Rothenbühler, M., O'Sullivan, C. J., Stortecky, S., Stefanini, G. G., Spitzer, E., Estill, J., Shrestha, N. R., Keiser, O., Jüni, P., & Pilgrim, T. (2014). Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. The Lancet. Global health, 2(12), e717–e726. https://doi.org/10.1016/S2214-109X(14)70310-9

Seckeler, M. D., & Hoke, T. R. (2011). The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clinical epidemiology, 3, 67–84. https://doi.org/10.2147/CLEP.S12977

Suciadi L, Karwiky G, Hidayat S. PT438. A profile of rheumatic heart disease at a cardiac center in Bandung City, Indonesia: an echocardiography study. Global Heart. (2014) 9:e258–9. doi: 10.1016/j.gheart.2014.03.2146

Suastika LOS, Wibhuti IBR, Nadha KB, Chowdhury M, Chowdhury J, Olejnik K, et al. Left ventricular dimension and ejection fraction values by echocardiography in adolescents: an epidemiology study in Bali, Indonesia. Original Res Abst Eur Heart J. (2018) 20:D21–34. doi: 10.1093/eurheartj/suy011

Topçu, S., & Uçar, T. (2024). Echocardiographic Screening of Rheumatic Heart Disease: Current Concepts and Challenges. Turkish archives of pediatrics, 59(1), 3–12. https://doi.org/10.5152/TurkArchPediatr.2024.23162

Padmavati, S., Sharma, K. B., & Jayaram, O. (1973). Epidemiology and prophylaxis of rheumatic fever in Delhi--a five year follow-up. Singapore medical journal, 14(3), 457–461.

Beaton, A., Okello, E., Rwebembera, J., Grobler, A., Engelman, D., Alepere, J., Canales, L., Carapetis, J., DeWyer, A., Lwabi, P., Mirabel, M., Mocumbi, A. O., Murali, M., Nakitto, M., Ndagire, E., Nunes, M. C. P., Omara, I. O., Sarnacki, R., Scheel, A., Wilson, N., … Steer, A. C. (2022). Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. The New England journal of medicine, 386(3), 230–240. https://doi.org/10.1056/NEJMoa2102074

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., 3rd, Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., Sundt, T. M., 3rd, Thomas, J. D., & ACC/AHA Task Force Members (2014). 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129(23), 2440–2492. https://doi.org/10.1161/CIR.0000000000000029

Faé, K. C., Diefenbach da Silva, D., Bilate, A. M., Tanaka, A. C., Pomerantzeff, P. M., Kiss, M. H., Silva, C. A., Cunha-Neto, E., Kalil, J., & Guilherme, L. (2008). PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. Journal of autoimmunity, 31(2), 136–141. https://doi.org/10.1016/j.jaut.2008.04.023

Marijon, E., Celermajer, D. S., Tafflet, M., El-Haou, S., Jani, D. N., Ferreira, B., Mocumbi, A. O., Paquet, C., Sidi, D., & Jouven, X. (2009). Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation, 120(8), 663–668. https://doi.org/10.1161/CIRCULATIONAHA.109.849190

Rwebembera, J., Beaton, A. Z., de Loizaga, S. R., Rocha, R. T. L., Doreen, N., Ssinabulya, I., Okello, E., Fraga, C. L., Galdino, B. F., Nunes, M. C. P., & Nascimento, B. R. (2021). The Global Impact of Rheumatic Heart Disease. Current cardiology reports, 23(11), 160. https://doi.org/10.1007/s11886-021-01592-2

Francis, J. R., Fairhurst, H., Hardefeldt, H., Brown, S., Ryan, C., Brown, K., Smith, G., Baartz, R., Horton, A., Whalley, G., Marangou, J., Kaethner, A., Draper, A. D., James, C. L., Mitchell, A. G., Yan, J., Ralph, A., & Remenyi, B. (2020). Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening. The Medical journal of Australia, 213(3), 118–123. https://doi.org/10.5694/mja2.50682

Noubiap, J. J., Agbor, V. N., Bigna, J. J., Kaze, A. D., Nyaga, U. F., & Mayosi, B. M. (2019). Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Scientific reports, 9(1), 17022. https://doi.org/10.1038/s41598-019-53540-4

Gürses, D., Koçak, G., Tutar, E., Özbarlas, N., & Turkish ARF study group (2021). Incidence and clinical characteristics of acute rheumatic fever in Turkey: Results of a nationwide multicentre study. Journal of paediatrics and child health, 57(12), 1949–1954. https://doi.org/10.1111/jpc.15619

Atalay, S., Tutar, E., Uçar, T., Topçu, S., Köse, S. K., & Doğan, M. T. (2019). Echocardiographic screening for rheumatic heart disease in Turkish schoolchildren. Cardiology in the young, 29(10), 1272–1277. https://doi.org/10.1017/S1047951119002075

Hunter, L. D., Monaghan, M., Lloyd, G., Lombard, C., Pecoraro, A. J. K., Doubell, A. F., & Herbst, P. G. (2020). Interscallop separations of the posterior mitral valve leaflet: a solution to the ‘borderline RHD’ conundrum? Open Heart, 7(2), e001452. https://doi.org/10.1136/openhrt-2020-001452

Downloads

Published

2024-11-30

How to Cite

Jochebet Irene, and Ciho Olfriani. 2024. “Advancing Rheumatic Heart Disease Management in Indonesia: Strengthening Early Detection, Targeted Screening, and Prevention Strategies”. The International Journal of Medical Science and Health Research 6 (3): 22-45. https://doi.org/10.70070/hh97hs61.